CHS Inc.
CHS Inc. (CHSCP) Stock Competitors & Peer Comparison
See (CHSCP) competitors and their performances in Stock Market.
Peer Comparison Table: Agricultural Farm Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CHSCP | $27.92 | +1.35% | 340.2M | N/A | N/A | +7.33% |
| ADM | $54.82 | -1.23% | 26.6B | 19.50 | $2.84 | +3.66% |
| TSN | $53.83 | -0.31% | 18.8B | 21.00 | $2.57 | +3.69% |
| BG | $76.88 | -0.06% | 15.5B | 9.92 | $7.79 | +3.55% |
| SFD | $23.98 | +0.78% | 9.4B | 10.52 | $2.27 | +2.11% |
| CALM | $105.02 | -0.81% | 5.1B | 4.21 | $24.95 | +6.46% |
| AGRO | $9.26 | -1.33% | 4.7B | 14.99 | $0.63 | +3.72% |
| IBA | $53.00 | -1.82% | 2.6B | 7.77 | $6.82 | N/A |
| FDP | $36.00 | +2.10% | 1.7B | 11.68 | $3.05 | +3.11% |
| VITL | $36.27 | -0.42% | 1.6B | 32.48 | $1.12 | N/A |
Stock Comparison
CHSCP vs ADM Comparison July 2025
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 340.2M. In comparison, ADM has a market cap of 26.6B. Regarding current trading prices, CHSCP is priced at $27.92, while ADM trades at $54.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas ADM's P/E ratio is 19.50. In terms of profitability, CHSCP's ROE is +0.05%, compared to ADM's ROE of +0.06%. Regarding short-term risk, CHSCP is less volatile compared to ADM. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check ADM's competition here
CHSCP vs TSN Comparison July 2025
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 340.2M. In comparison, TSN has a market cap of 18.8B. Regarding current trading prices, CHSCP is priced at $27.92, while TSN trades at $53.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas TSN's P/E ratio is 21.00. In terms of profitability, CHSCP's ROE is +0.05%, compared to TSN's ROE of +0.05%. Regarding short-term risk, CHSCP is less volatile compared to TSN. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check TSN's competition here
CHSCP vs BG Comparison July 2025
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 340.2M. In comparison, BG has a market cap of 15.5B. Regarding current trading prices, CHSCP is priced at $27.92, while BG trades at $76.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas BG's P/E ratio is 9.92. In terms of profitability, CHSCP's ROE is +0.05%, compared to BG's ROE of +0.11%. Regarding short-term risk, CHSCP is less volatile compared to BG. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check BG's competition here
CHSCP vs SFD Comparison July 2025
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 340.2M. In comparison, SFD has a market cap of 9.4B. Regarding current trading prices, CHSCP is priced at $27.92, while SFD trades at $23.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas SFD's P/E ratio is 10.52. In terms of profitability, CHSCP's ROE is +0.05%, compared to SFD's ROE of +0.08%. Regarding short-term risk, CHSCP is less volatile compared to SFD. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check SFD's competition here
CHSCP vs CALM Comparison July 2025
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 340.2M. In comparison, CALM has a market cap of 5.1B. Regarding current trading prices, CHSCP is priced at $27.92, while CALM trades at $105.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas CALM's P/E ratio is 4.21. In terms of profitability, CHSCP's ROE is +0.05%, compared to CALM's ROE of +0.55%. Regarding short-term risk, CHSCP is less volatile compared to CALM. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check CALM's competition here
CHSCP vs AGRO Comparison July 2025
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 340.2M. In comparison, AGRO has a market cap of 4.7B. Regarding current trading prices, CHSCP is priced at $27.92, while AGRO trades at $9.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas AGRO's P/E ratio is 14.99. In terms of profitability, CHSCP's ROE is +0.05%, compared to AGRO's ROE of +0.05%. Regarding short-term risk, CHSCP is less volatile compared to AGRO. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check AGRO's competition here
CHSCP vs IBA Comparison July 2025
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 340.2M. In comparison, IBA has a market cap of 2.6B. Regarding current trading prices, CHSCP is priced at $27.92, while IBA trades at $53.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas IBA's P/E ratio is 7.77. In terms of profitability, CHSCP's ROE is +0.05%, compared to IBA's ROE of +0.12%. Regarding short-term risk, CHSCP is less volatile compared to IBA. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check IBA's competition here
CHSCP vs FDP Comparison July 2025
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 340.2M. In comparison, FDP has a market cap of 1.7B. Regarding current trading prices, CHSCP is priced at $27.92, while FDP trades at $36.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas FDP's P/E ratio is 11.68. In terms of profitability, CHSCP's ROE is +0.05%, compared to FDP's ROE of +0.07%. Regarding short-term risk, CHSCP is less volatile compared to FDP. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check FDP's competition here
CHSCP vs VITL Comparison July 2025
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 340.2M. In comparison, VITL has a market cap of 1.6B. Regarding current trading prices, CHSCP is priced at $27.92, while VITL trades at $36.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas VITL's P/E ratio is 32.48. In terms of profitability, CHSCP's ROE is +0.05%, compared to VITL's ROE of +0.20%. Regarding short-term risk, CHSCP is less volatile compared to VITL. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check VITL's competition here
CHSCP vs DOLE Comparison July 2025
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 340.2M. In comparison, DOLE has a market cap of 1.4B. Regarding current trading prices, CHSCP is priced at $27.92, while DOLE trades at $14.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas DOLE's P/E ratio is 11.72. In terms of profitability, CHSCP's ROE is +0.05%, compared to DOLE's ROE of +0.07%. Regarding short-term risk, CHSCP is less volatile compared to DOLE. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check DOLE's competition here
CHSCP vs LND Comparison July 2025
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 340.2M. In comparison, LND has a market cap of 377M. Regarding current trading prices, CHSCP is priced at $27.92, while LND trades at $3.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas LND's P/E ratio is 6.76. In terms of profitability, CHSCP's ROE is +0.05%, compared to LND's ROE of +0.14%. Regarding short-term risk, CHSCP and LND have similar daily volatility (0.80).Check LND's competition here
CHSCP vs CHSCN Comparison July 2025
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 340.2M. In comparison, CHSCN has a market cap of 339.1M. Regarding current trading prices, CHSCP is priced at $27.92, while CHSCN trades at $25.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas CHSCN's P/E ratio is N/A. In terms of profitability, CHSCP's ROE is +0.05%, compared to CHSCN's ROE of +0.05%. Regarding short-term risk, CHSCP is more volatile compared to CHSCN. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCP.Check CHSCN's competition here
CHSCP vs CHSCM Comparison July 2025
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 340.2M. In comparison, CHSCM has a market cap of 338.5M. Regarding current trading prices, CHSCP is priced at $27.92, while CHSCM trades at $24.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas CHSCM's P/E ratio is N/A. In terms of profitability, CHSCP's ROE is +0.05%, compared to CHSCM's ROE of +0.05%. Regarding short-term risk, CHSCP is more volatile compared to CHSCM. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCP.Check CHSCM's competition here
CHSCP vs CHSCL Comparison July 2025
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 340.2M. In comparison, CHSCL has a market cap of 338.5M. Regarding current trading prices, CHSCP is priced at $27.92, while CHSCL trades at $25.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas CHSCL's P/E ratio is N/A. In terms of profitability, CHSCP's ROE is +0.05%, compared to CHSCL's ROE of +0.05%. Regarding short-term risk, CHSCP is more volatile compared to CHSCL. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCP.Check CHSCL's competition here
CHSCP vs CHSCO Comparison July 2025
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 340.2M. In comparison, CHSCO has a market cap of 338.5M. Regarding current trading prices, CHSCP is priced at $27.92, while CHSCO trades at $26.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas CHSCO's P/E ratio is N/A. In terms of profitability, CHSCP's ROE is +0.05%, compared to CHSCO's ROE of +0.05%. Regarding short-term risk, CHSCP is more volatile compared to CHSCO. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCP.Check CHSCO's competition here
CHSCP vs LMNR Comparison July 2025
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 340.2M. In comparison, LMNR has a market cap of 274.8M. Regarding current trading prices, CHSCP is priced at $27.92, while LMNR trades at $15.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas LMNR's P/E ratio is -117.00. In terms of profitability, CHSCP's ROE is +0.05%, compared to LMNR's ROE of -0.01%. Regarding short-term risk, CHSCP is less volatile compared to LMNR. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check LMNR's competition here
CHSCP vs ALCO Comparison July 2025
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 340.2M. In comparison, ALCO has a market cap of 248.3M. Regarding current trading prices, CHSCP is priced at $27.92, while ALCO trades at $32.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas ALCO's P/E ratio is -1.76. In terms of profitability, CHSCP's ROE is +0.05%, compared to ALCO's ROE of -0.63%. Regarding short-term risk, CHSCP is less volatile compared to ALCO. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check ALCO's competition here
CHSCP vs AFRI Comparison July 2025
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 340.2M. In comparison, AFRI has a market cap of 209.6M. Regarding current trading prices, CHSCP is priced at $27.92, while AFRI trades at $7.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas AFRI's P/E ratio is -8.95. In terms of profitability, CHSCP's ROE is +0.05%, compared to AFRI's ROE of -1.48%. Regarding short-term risk, CHSCP is more volatile compared to AFRI. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCP.Check AFRI's competition here
CHSCP vs VFF Comparison July 2025
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 340.2M. In comparison, VFF has a market cap of 170.8M. Regarding current trading prices, CHSCP is priced at $27.92, while VFF trades at $1.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas VFF's P/E ratio is -4.34. In terms of profitability, CHSCP's ROE is +0.05%, compared to VFF's ROE of -0.15%. Regarding short-term risk, CHSCP is less volatile compared to VFF. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check VFF's competition here
CHSCP vs AGFS Comparison July 2025
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 340.2M. In comparison, AGFS has a market cap of 161.2M. Regarding current trading prices, CHSCP is priced at $27.92, while AGFS trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas AGFS's P/E ratio is -2.61. In terms of profitability, CHSCP's ROE is +0.05%, compared to AGFS's ROE of -0.12%. Regarding short-term risk, CHSCP is more volatile compared to AGFS. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCP.Check AGFS's competition here
CHSCP vs LOCL Comparison July 2025
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 340.2M. In comparison, LOCL has a market cap of 65.1M. Regarding current trading prices, CHSCP is priced at $27.92, while LOCL trades at $3.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas LOCL's P/E ratio is -0.19. In terms of profitability, CHSCP's ROE is +0.05%, compared to LOCL's ROE of +1.61%. Regarding short-term risk, CHSCP is less volatile compared to LOCL. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check LOCL's competition here
CHSCP vs PME Comparison July 2025
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 340.2M. In comparison, PME has a market cap of 23.2M. Regarding current trading prices, CHSCP is priced at $27.92, while PME trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas PME's P/E ratio is 13.50. In terms of profitability, CHSCP's ROE is +0.05%, compared to PME's ROE of -0.03%. Regarding short-term risk, CHSCP is less volatile compared to PME. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check PME's competition here
CHSCP vs DTCK Comparison July 2025
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 340.2M. In comparison, DTCK has a market cap of 20.3M. Regarding current trading prices, CHSCP is priced at $27.92, while DTCK trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas DTCK's P/E ratio is -5.91. In terms of profitability, CHSCP's ROE is +0.05%, compared to DTCK's ROE of +0.04%. Regarding short-term risk, CHSCP is less volatile compared to DTCK. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check DTCK's competition here
CHSCP vs APPH Comparison July 2025
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 340.2M. In comparison, APPH has a market cap of 10.3M. Regarding current trading prices, CHSCP is priced at $27.92, while APPH trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas APPH's P/E ratio is -0.14. In terms of profitability, CHSCP's ROE is +0.05%, compared to APPH's ROE of -0.55%. Regarding short-term risk, CHSCP is less volatile compared to APPH. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check APPH's competition here
CHSCP vs APPHW Comparison July 2025
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 340.2M. In comparison, APPHW has a market cap of 10.3M. Regarding current trading prices, CHSCP is priced at $27.92, while APPHW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas APPHW's P/E ratio is N/A. In terms of profitability, CHSCP's ROE is +0.05%, compared to APPHW's ROE of -0.55%. Regarding short-term risk, CHSCP is less volatile compared to APPHW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check APPHW's competition here
CHSCP vs AFRIW Comparison July 2025
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 340.2M. In comparison, AFRIW has a market cap of 10.1M. Regarding current trading prices, CHSCP is priced at $27.92, while AFRIW trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas AFRIW's P/E ratio is -16.31. In terms of profitability, CHSCP's ROE is +0.05%, compared to AFRIW's ROE of -1.48%. Regarding short-term risk, CHSCP is less volatile compared to AFRIW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check AFRIW's competition here
CHSCP vs EDBLW Comparison July 2025
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 340.2M. In comparison, EDBLW has a market cap of 7.2M. Regarding current trading prices, CHSCP is priced at $27.92, while EDBLW trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas EDBLW's P/E ratio is -0.08. In terms of profitability, CHSCP's ROE is +0.05%, compared to EDBLW's ROE of -4.25%. Regarding short-term risk, CHSCP is less volatile compared to EDBLW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check EDBLW's competition here
CHSCP vs EDBL Comparison July 2025
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 340.2M. In comparison, EDBL has a market cap of 7.2M. Regarding current trading prices, CHSCP is priced at $27.92, while EDBL trades at $2.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas EDBL's P/E ratio is 0.01. In terms of profitability, CHSCP's ROE is +0.05%, compared to EDBL's ROE of -4.25%. Regarding short-term risk, CHSCP is less volatile compared to EDBL. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check EDBL's competition here
CHSCP vs SDOT Comparison July 2025
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 340.2M. In comparison, SDOT has a market cap of 6.7M. Regarding current trading prices, CHSCP is priced at $27.92, while SDOT trades at $1.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas SDOT's P/E ratio is 0.89. In terms of profitability, CHSCP's ROE is +0.05%, compared to SDOT's ROE of +0.19%. Regarding short-term risk, CHSCP is less volatile compared to SDOT. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check SDOT's competition here
CHSCP vs SANW Comparison July 2025
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 340.2M. In comparison, SANW has a market cap of 3.9M. Regarding current trading prices, CHSCP is priced at $27.92, while SANW trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas SANW's P/E ratio is -0.13. In terms of profitability, CHSCP's ROE is +0.05%, compared to SANW's ROE of -1.24%. Regarding short-term risk, CHSCP is less volatile compared to SANW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check SANW's competition here
CHSCP vs AQB Comparison July 2025
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 340.2M. In comparison, AQB has a market cap of 3.1M. Regarding current trading prices, CHSCP is priced at $27.92, while AQB trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas AQB's P/E ratio is -0.03. In terms of profitability, CHSCP's ROE is +0.05%, compared to AQB's ROE of +0.06%. Regarding short-term risk, CHSCP is less volatile compared to AQB. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check AQB's competition here
CHSCP vs KAL Comparison July 2025
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 340.2M. In comparison, KAL has a market cap of 2.1M. Regarding current trading prices, CHSCP is priced at $27.92, while KAL trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas KAL's P/E ratio is -0.01. In terms of profitability, CHSCP's ROE is +0.05%, compared to KAL's ROE of -0.19%. Regarding short-term risk, CHSCP is less volatile compared to KAL. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check KAL's competition here
CHSCP vs KALWW Comparison July 2025
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 340.2M. In comparison, KALWW has a market cap of 2.1M. Regarding current trading prices, CHSCP is priced at $27.92, while KALWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas KALWW's P/E ratio is N/A. In terms of profitability, CHSCP's ROE is +0.05%, compared to KALWW's ROE of -0.19%. Regarding short-term risk, CHSCP is less volatile compared to KALWW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check KALWW's competition here
CHSCP vs AGRI Comparison July 2025
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 340.2M. In comparison, AGRI has a market cap of 1.7M. Regarding current trading prices, CHSCP is priced at $27.92, while AGRI trades at $5.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas AGRI's P/E ratio is -0.16. In terms of profitability, CHSCP's ROE is +0.05%, compared to AGRI's ROE of +0.10%. Regarding short-term risk, CHSCP is less volatile compared to AGRI. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check AGRI's competition here
CHSCP vs AAGRW Comparison July 2025
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 340.2M. In comparison, AAGRW has a market cap of 315.5K. Regarding current trading prices, CHSCP is priced at $27.92, while AAGRW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas AAGRW's P/E ratio is N/A. In terms of profitability, CHSCP's ROE is +0.05%, compared to AAGRW's ROE of +1.14%. Regarding short-term risk, CHSCP is less volatile compared to AAGRW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check AAGRW's competition here
CHSCP vs AGRIW Comparison July 2025
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 340.2M. In comparison, AGRIW has a market cap of 69.2K. Regarding current trading prices, CHSCP is priced at $27.92, while AGRIW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas AGRIW's P/E ratio is -0.01. In terms of profitability, CHSCP's ROE is +0.05%, compared to AGRIW's ROE of +0.10%. Regarding short-term risk, CHSCP is less volatile compared to AGRIW. This indicates potentially lower risk in terms of short-term price fluctuations for CHSCP.Check AGRIW's competition here
CHSCP vs AAGR Comparison July 2025
CHSCP plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CHSCP stands at 340.2M. In comparison, AAGR has a market cap of 5.8K. Regarding current trading prices, CHSCP is priced at $27.92, while AAGR trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CHSCP currently has a P/E ratio of N/A, whereas AAGR's P/E ratio is N/A. In terms of profitability, CHSCP's ROE is +0.05%, compared to AAGR's ROE of +1.14%. Regarding short-term risk, CHSCP is more volatile compared to AAGR. This indicates potentially higher risk in terms of short-term price fluctuations for CHSCP.Check AAGR's competition here